Cargando…

Emergence of Intrahepatic Cholangiocarcinoma: How High-Throughput Technologies Expedite the Solutions for a Rare Cancer Type

Intrahepatic cholangiocarcinoma (ICC) is the cancer of the intrahepatic bile ducts, and together with hepatocellular carcinoma (HCC), constitute the majority of primary liver cancers. ICC is a rare disorder as its overall incidence is < 1/100,000 in the United States and Europe. However, it shows...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shiao, Meng-Shin, Chiablaem, Khajeelak, Charoensawan, Varodom, Ngamphaiboon, Nuttapong, Jinawath, Natini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Genetics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104394/ https://www.ncbi.nlm.nih.gov/pubmed/30158952 http://dx.doi.org/10.3389/fgene.2018.00309

Ejemplares similares

Bridging the gap between clinicians and systems biologists: from network biology to translational biomedical research
por: Jinawath, Natini, et al.
Publicado: (2016)

Capturing tumour heterogeneity in pre- and post-chemotherapy colorectal cancer ascites-derived cells using single-cell RNA-sequencing
por: Poonpanichakul, Tiraput, et al.
Publicado: (2021)

Discrepancy in p16 expression in patients with HPV-associated head and neck squamous cell carcinoma in Thailand: clinical characteristics and survival outcomes
por: Arsa, Lalida, et al.
Publicado: (2021)

Plasma extracellular vesicle microRNA‐491‐5p as diagnostic and prognostic marker for head and neck squamous cell carcinoma
por: Panvongsa, Wittaya, et al.
Publicado: (2021)

Proteomic Studies of Cholangiocarcinoma and Hepatocellular Carcinoma Cell Secretomes
por: Srisomsap, Chantragan, et al.
Publicado: (2010)

Novel SOX10 Mutations in Waardenburg Syndrome: Functional Characterization and Genotype-Phenotype Analysis
por: Thongpradit, Supranee, et al.
Publicado: (2020)

CEACAM6 gene expression in intrahepatic cholangiocarcinoma
por: Ieta, K, et al.
Publicado: (2006)

Copy Number Variation in Thai Population
por: Suktitipat, Bhoom, et al.
Publicado: (2014)

High-Throughput Screening for Biomarker Discovery
por: Janvilisri, Tavan, et al.
Publicado: (2015)

Case report: Molecular analysis of a 47,XY,+21/46,XX chimera using SNP microarray and review of literature
por: Charalsawadi, Chariyawan, et al.
Publicado: (2022)

TP53 /KRAS Co-Mutations Create Divergent Prognosis Signatures in Intrahepatic Cholangiocarcinoma
por: Guo, Chunguang, et al.
Publicado: (2022)

Exploring the role of tumor stemness and the potential of stemness-related risk model in the prognosis of intrahepatic cholangiocarcinoma
por: Yue, Yuan, et al.
Publicado: (2023)

The impact of decreased expression of SVEP1 on abnormal neovascularization and poor prognosis in patients with intrahepatic cholangiocarcinoma
por: Chen, Liwei, et al.
Publicado: (2023)

Development of a Prognostic Signature Based on Single-Cell RNA Sequencing Data of Immune Cells in Intrahepatic Cholangiocarcinoma
por: Su, Miao, et al.
Publicado: (2021)

Large-scale comparative transcriptomic analysis of temperature-responsive genes in Arabidopsis thaliana
por: Sriden, Napaporn, et al.
Publicado: (2022)

Enhancement of Migration and Invasion of Gastric Cancer Cells by IQGAP3
por: Jinawath, Natini, et al.
Publicado: (2020)

Circulating Exosomal miRNAs as Biomarkers in Epithelial Ovarian Cancer
por: Shiao, Meng-Shin, et al.
Publicado: (2021)

Intrahepatic Sarcomatoid Cholangiocarcinoma
por: Malhotra, Shalini, et al.
Publicado: (2010)

Asbestos and Intrahepatic Cholangiocarcinoma
por: Brandi, Giovanni, et al.
Publicado: (2020)

Management of Intrahepatic Cholangiocarcinoma
por: Kodali, Sudha, et al.
Publicado: (2021)

An extremely rare case of intrahepatic sarcomatoid cholangiocarcinoma
por: Lieu, Dau Quang, et al.
Publicado: (2023)

Expedited Radiation Biodosimetry by Automated Dicentric Chromosome Identification (ADCI) and Dose Estimation
por: Shirley, Ben, et al.
Publicado: (2017)

Two Varieties of Intrahepatic Cholangiocarcinoma
por: Nagorney, David M.
Publicado: (1994)

Intrahepatic Cholangiocarcinoma with Sarcomatous Changes
por: Inoue, Yoshiyuki, et al.
Publicado: (2012)

Serum Markers of Intrahepatic Cholangiocarcinoma
por: Malaguarnera, Giulia, et al.
Publicado: (2013)

Intrahepatic cholangiocarcinoma: current perspectives
por: Buettner, Stefan, et al.
Publicado: (2017)

Intratumoral heterogeneity of intrahepatic cholangiocarcinoma
por: Walter, Dirk, et al.
Publicado: (2017)

Molecular heterogeneity in intrahepatic cholangiocarcinoma
por: Ahn, Keun Soo, et al.
Publicado: (2020)

Recurrent Intrahepatic Cholangiocarcinoma – Review
por: Bekki, Yuki, et al.
Publicado: (2021)

Stereotactic radiotherapy for intrahepatic cholangiocarcinoma
por: Borakati, Aditya, et al.
Publicado: (2022)

Surgical Aspects of Intrahepatic Cholangiocarcinoma
por: Kupietzky, Amram, et al.
Publicado: (2022)

Locoregional Therapy for Intrahepatic Cholangiocarcinoma
por: Owen, Mackenzie, et al.
Publicado: (2023)

Lineage-specific expansion of DNA-binding transcription factor families
por: Charoensawan, Varodom, et al.
Publicado: (2010)

Genomic repertoires of DNA-binding transcription factors across the tree of life
por: Charoensawan, Varodom, et al.
Publicado: (2010)

The Application of High-Throughput Technologies for the Study of Microbiome and Cancer
por: Wei, Lu Qi, et al.
Publicado: (2021)

Impact of Weight Loss on Patients with Locally Advanced Esophageal and Esophagogastric Junction Cancers Treated with Chemoradiotherapy
por: Wiwitkeyoonwong, Jirapath, et al.
Publicado: (2021)

Uncovering the interplay between DNA sequence preferences of transcription factors and nucleosomes
por: Teichmann, Sarah A., et al.
Publicado: (2012)

MicroRNAs and oncogenic transcriptional regulatory networks controlling metabolic reprogramming in cancers
por: Pinweha, Pannapa, et al.
Publicado: (2016)

Editorial: Multi-Disciplinary Approaches to Plant Responses to Climate Change
por: Charoensawan, Varodom, et al.
Publicado: (2022)

Epigallocatechin gallate-zinc oxide co-crystalline nanoparticles as an anticancer drug that is non-toxic to normal cells
por: Samutprasert, Pawatsanai, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_vc0upp78ngp3pa82jfoommmi0u